---
title: "Genpact surges to record high after results, outlook"
date: "2025-02-07 23:40:08"
summary: "** Genpact up 11.6% to $55.13 after hitting record high of $56.76 and on track for biggest daily pct gain since Aug 9** The professional services company reported Q4 adj EPS and revenue that topped Street estimates after the close on Thursday while also giving its Q1 and FY 2025..."
categories:
  - "Reuters"
lang:
  - "en"
translations:
  - "en"
tags:
  - "Reuters"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

\*\* Genpact up 11.6% to $55.13 after hitting record high of $56.76 and on track for biggest daily pct gain since Aug 9

\*\* The professional services company reported Q4 adj EPS and revenue that topped Street estimates after the close on Thursday while also giving its Q1 and FY 2025 outlook

\*\* BMO raised its price target on the stock to $58 from $53 but kept its "market perform" rating intact, noting the FY2025 guidance "appears prudent" but the firm said it still questions the durability of growth longer term.

\*\* Jefferies equity analyst Surinder Third reiterated "buy" rating, said, "Many of the strategic changes implemented earlier in the year appear to have coalesced, which leads us to believe growth has the potential to show further improvement in 2025."

\*\* Needham raised its price target on the stock to $65 from $55 per share

\*\* Of 11 analysts covering Genpact Ltd, breakdown of recommendations are 5 "strong buy" or "buy" and 6 "hold" ratings

\*\* Median price target of $57 is up from $48 a month ago and from $41 on Nov 7

[Reuters](https://www.tradingview.com/news/reuters.com,2025:newsml_L1N3OY0PU:0-genpact-surges-to-record-high-after-results-outlook/)
